Cargando…

Depression in HIV-positive women is associated with changes in antiretroviral treatment regimens

INTRODUCTION: Depression is a co-morbidity of clinical significance in HIV-positive patients with an estimated prevalence of more than 20%. Sex and gender-related differences in depression are well described in HIV-negative populations, demonstrating that more women are being affected. So far little...

Descripción completa

Detalles Bibliográficos
Autores principales: Philippe Küpper-Tetzel, Claus, Göpel, Siri, Khaykin, Pavel, Wolf, Timo, Stephan, Christoph, Herrmann, Eva, Brodt, Hans-Reinhard, Haberl, Annette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International AIDS Society 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225293/
https://www.ncbi.nlm.nih.gov/pubmed/25397466
http://dx.doi.org/10.7448/IAS.17.4.19720
_version_ 1782343476335083520
author Philippe Küpper-Tetzel, Claus
Göpel, Siri
Khaykin, Pavel
Wolf, Timo
Stephan, Christoph
Herrmann, Eva
Brodt, Hans-Reinhard
Haberl, Annette
author_facet Philippe Küpper-Tetzel, Claus
Göpel, Siri
Khaykin, Pavel
Wolf, Timo
Stephan, Christoph
Herrmann, Eva
Brodt, Hans-Reinhard
Haberl, Annette
author_sort Philippe Küpper-Tetzel, Claus
collection PubMed
description INTRODUCTION: Depression is a co-morbidity of clinical significance in HIV-positive patients with an estimated prevalence of more than 20%. Sex and gender-related differences in depression are well described in HIV-negative populations, demonstrating that more women are being affected. So far little is known about frequency and characteristics of depression in HIV-positive men and women. MATERIALS AND METHODS: Primary objective of our prospective epidemiological study was the evaluation of the Beck score for depression in male and female patients of the Frankfurt HIV Cohort. The Beck Depression Inventory (BDI-II) is a self-report symptom inventory made up of 21 questions, each with 4 possible answers, correlating with a certain point value. Interpretation: score 14–19: mild depression; score 20–28: moderate depression; score ≥29: severe depression. Secondary objectives of the analysis were factors that might possibly influence the disposition for depression in HIV-positive patients, e.g. age, antiretroviral treatment history, co-morbidities and socioeconomic status. RESULTS: Between January and October 2013, 348 patients were enrolled in the study, 161 women and 187 men of the Frankfurt HIV Cohort, who had a routine appointment at the HIV-Center of the University Clinic Frankfurt. The mean age of all study participants was 45 years (range 22–80). The majority of patients were on antiretroviral therapy (91%) at study entrance. The median BDI-II score in all patients was 8 (0–49); in female patients 10 (0–42), in male patients 6 (0–49), respectively (Table 1). Significant more women than men showed a score for moderate depression (p=0.006). Factors associated with a BDI-II score ≥20 in women were older age (>45 years), living alone, unemployment and the number of prior changes in antiretroviral therapy. CONCLUSIONS: Depression in people living with HIV shows sex and gender-related differences that might also influence antiretroviral treatment strategies. HIV specialists should be aware of these gender-specific aspects and consider routine screening for depression especially in female patients of older age or those with multiple therapy changes in history.
format Online
Article
Text
id pubmed-4225293
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher International AIDS Society
record_format MEDLINE/PubMed
spelling pubmed-42252932014-11-12 Depression in HIV-positive women is associated with changes in antiretroviral treatment regimens Philippe Küpper-Tetzel, Claus Göpel, Siri Khaykin, Pavel Wolf, Timo Stephan, Christoph Herrmann, Eva Brodt, Hans-Reinhard Haberl, Annette J Int AIDS Soc Poster Sessions – Abstract P188 INTRODUCTION: Depression is a co-morbidity of clinical significance in HIV-positive patients with an estimated prevalence of more than 20%. Sex and gender-related differences in depression are well described in HIV-negative populations, demonstrating that more women are being affected. So far little is known about frequency and characteristics of depression in HIV-positive men and women. MATERIALS AND METHODS: Primary objective of our prospective epidemiological study was the evaluation of the Beck score for depression in male and female patients of the Frankfurt HIV Cohort. The Beck Depression Inventory (BDI-II) is a self-report symptom inventory made up of 21 questions, each with 4 possible answers, correlating with a certain point value. Interpretation: score 14–19: mild depression; score 20–28: moderate depression; score ≥29: severe depression. Secondary objectives of the analysis were factors that might possibly influence the disposition for depression in HIV-positive patients, e.g. age, antiretroviral treatment history, co-morbidities and socioeconomic status. RESULTS: Between January and October 2013, 348 patients were enrolled in the study, 161 women and 187 men of the Frankfurt HIV Cohort, who had a routine appointment at the HIV-Center of the University Clinic Frankfurt. The mean age of all study participants was 45 years (range 22–80). The majority of patients were on antiretroviral therapy (91%) at study entrance. The median BDI-II score in all patients was 8 (0–49); in female patients 10 (0–42), in male patients 6 (0–49), respectively (Table 1). Significant more women than men showed a score for moderate depression (p=0.006). Factors associated with a BDI-II score ≥20 in women were older age (>45 years), living alone, unemployment and the number of prior changes in antiretroviral therapy. CONCLUSIONS: Depression in people living with HIV shows sex and gender-related differences that might also influence antiretroviral treatment strategies. HIV specialists should be aware of these gender-specific aspects and consider routine screening for depression especially in female patients of older age or those with multiple therapy changes in history. International AIDS Society 2014-11-02 /pmc/articles/PMC4225293/ /pubmed/25397466 http://dx.doi.org/10.7448/IAS.17.4.19720 Text en © 2014 Philippe Küpper-Tetzel C et al; licensee International AIDS Society http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Poster Sessions – Abstract P188
Philippe Küpper-Tetzel, Claus
Göpel, Siri
Khaykin, Pavel
Wolf, Timo
Stephan, Christoph
Herrmann, Eva
Brodt, Hans-Reinhard
Haberl, Annette
Depression in HIV-positive women is associated with changes in antiretroviral treatment regimens
title Depression in HIV-positive women is associated with changes in antiretroviral treatment regimens
title_full Depression in HIV-positive women is associated with changes in antiretroviral treatment regimens
title_fullStr Depression in HIV-positive women is associated with changes in antiretroviral treatment regimens
title_full_unstemmed Depression in HIV-positive women is associated with changes in antiretroviral treatment regimens
title_short Depression in HIV-positive women is associated with changes in antiretroviral treatment regimens
title_sort depression in hiv-positive women is associated with changes in antiretroviral treatment regimens
topic Poster Sessions – Abstract P188
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225293/
https://www.ncbi.nlm.nih.gov/pubmed/25397466
http://dx.doi.org/10.7448/IAS.17.4.19720
work_keys_str_mv AT philippekuppertetzelclaus depressioninhivpositivewomenisassociatedwithchangesinantiretroviraltreatmentregimens
AT gopelsiri depressioninhivpositivewomenisassociatedwithchangesinantiretroviraltreatmentregimens
AT khaykinpavel depressioninhivpositivewomenisassociatedwithchangesinantiretroviraltreatmentregimens
AT wolftimo depressioninhivpositivewomenisassociatedwithchangesinantiretroviraltreatmentregimens
AT stephanchristoph depressioninhivpositivewomenisassociatedwithchangesinantiretroviraltreatmentregimens
AT herrmanneva depressioninhivpositivewomenisassociatedwithchangesinantiretroviraltreatmentregimens
AT brodthansreinhard depressioninhivpositivewomenisassociatedwithchangesinantiretroviraltreatmentregimens
AT haberlannette depressioninhivpositivewomenisassociatedwithchangesinantiretroviraltreatmentregimens